Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program
about
Translating research into practice: the role of provider-based research networks in the diffusion of an evidence-based colon cancer treatment innovation.Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adultsContext matters: measuring implementation climate among individuals and groups.Differential receipt of sentinel lymph node biopsy within practice-based research networks.Provider-based research networks demonstrate greater hospice use for minority patients with lung cancer.Factors associated with adherence to an end-of-study biopsy: lessons from the prostate cancer prevention trial (SWOG-Coordinated Intergroup Study S9217)Organizational and physician factors associated with patient enrollment in cancer clinical trials.The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovationRetention of black and white participants in the selenium and vitamin E cancer prevention trial (SWOG-coordinated intergroup study S0000).Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community.African American women's perceptions of cancer clinical trials.Determining the predictors of innovation implementation in healthcare: a quantitative analysis of implementation effectiveness.Provider-based research networks and diffusion of surgical technologies among patients with early-stage kidney cancer.Creating a "culture of research" in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers ProgramThe meaning and measurement of implementation climateSustainability and performance of the National Cancer Institute's Community Clinical Oncology ProgramAdvancing implementation science through measure development and evaluation: a study protocolA method for analyzing the business case for provider participation in the National Cancer Institute's Community Clinical Oncology Program and similar federally funded, provider-based research networks.Cancer Care Delivery Research: Building the Evidence Base to Support Practice Change in Community OncologyRacial Differences in Diffusion of Intensity-Modulated Radiation Therapy for Localized Prostate Cancer.Organizational designs for achieving high treatment trial enrollment: a fuzzy-set analysis of the community clinical oncology program.Implementing community-based provider participation in research: an empirical study.Does the engagement of clinicians and organisations in research improve healthcare performance: a three-stage reviewCooperative Group Trials in the Community Setting.Enrollment and Racial Disparities in Cancer Treatment Clinical Trials in North Carolina.A surveillance system for monitoring, public reporting, and improving minority access to cancer clinical trialsPublicly funded clinical trials and the future of cancer careAchieving high cancer control trial enrollment in the community setting: an analysis of the Community Clinical Oncology Program.The business case for provider participation in clinical trials research: an application to the National Cancer Institute's community clinical oncology program.Early-phase clinical trials in the community: results from the national cancer institute community cancer centers program early-phase working group baseline assessment.Why providers participate in clinical trials: considering the National Cancer Institute's Community Clinical Oncology Program.Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology ProgramChallenges and facilitators of community clinical oncology program participation: a qualitative study.Impact of the National Cancer Institute Community Cancer Centers Program on Clinical Trial and Related Activities at a Community Cancer Center in Rural NebraskaThe relationship between Clinical Trial Network protocol involvement and quality of substance use disorder treatmentBarriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer.Meausures of organizational characteristics associated with adoption and/or implementation of innovations: A systematic review.Strategies for Translating Evidence-Based Medicine in Lung Cancer into Community Practice.Next steps to improve disparities in lung cancer treatment clinical trial enrollment.Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program Experience.
P2860
Q30417975-9E9755F5-D99A-49AE-93D0-1F2136BE3A68Q30418988-0D30BA93-58D2-4AFF-B50F-37F11EF787BFQ33576110-857F502E-2E03-4108-8A12-5EEE13BFCB93Q33842120-9F30CB8D-4B55-467B-9F1E-E83C5445FCABQ33890488-D60124C7-9B92-43DB-8C76-364F818513BCQ33992410-5D7D637B-16EC-447C-BA78-A5277827DEF4Q34145546-6D4A57F1-7D89-47EF-AE78-3E56A9BDE940Q34568758-E2373E3D-8714-42B7-8AC7-C36F22E81979Q34641857-6D83D987-44D4-49D6-B88E-2367DC39EA1AQ34734413-F0A79258-330E-4EA4-9B4B-D8141C84BB85Q34998611-BAB8955F-FC39-464F-A59A-7276D080B7E3Q35016041-518139ED-79D6-44ED-84E9-55C094AA1E75Q35154954-E8C1ED25-26FC-4DD2-ACCE-BC82A4B033FBQ35572502-9725A60A-D12C-4AE8-99B6-FDD7264F6C91Q35574364-3982F654-EF9D-4D8A-826F-CAD03AF1B695Q35661170-6B2CA135-2388-41E2-99B0-90B921F837CBQ35879719-6CE242C3-F7DE-456E-A710-264A63BF36D5Q35881604-29B4A1CE-7F4C-4912-B36E-912EAA95EAB7Q36026000-C48A1E5A-22D3-411E-BB70-C26EE14E699FQ36062411-5E43931D-5A82-4C60-8384-6430D41B585BQ36226295-FCF3E33A-B6CD-437F-A221-CD183288FD0BQ36351763-0D65E789-FB93-477C-B4B6-E75C694D84EEQ36374374-AF18BB37-ABA8-40AB-A253-CE1581E2D9CAQ36408320-40C1CAC9-6112-461C-8FEA-93E6267A6E05Q36467761-B5BDA3D3-CFC3-4237-83CB-AD42CE2E114FQ36517038-5155ED69-48EF-46FE-8F3C-CEFBFF6AFBB9Q36630481-C0104BA1-FAF6-47A3-B5F2-B7B31B4F3F35Q36675469-D8B440F3-355F-4BC4-AA76-723DC06D6BECQ36675653-E2B20FD2-9B6C-4EBE-B038-F5883E34D6CFQ36678241-337A18E2-42D1-458A-B076-0024DAFF617CQ36994646-D0C55643-B613-418C-BDA4-82852137DC58Q37125017-C0314ACA-A9F1-475B-AAEB-84680C76327DQ37149562-B456F3BD-DE17-4570-BACB-03C5ACC007EDQ37157672-8EB14F55-B578-4718-ADFF-7300D1D2F1D2Q37419480-56A0DD6A-3AFC-4A4C-9A00-5C8951BEBC42Q37461392-B3FA7412-D0FB-4FF8-8769-82143F063A3AQ38611321-C4980B64-536B-4AC1-B061-0ADE8CC4FCF5Q39123715-AC7EC4AA-2C0D-4A39-AF1E-19F18B393EFAQ42314909-9AD896CC-37B7-4643-803D-6C5660B72BABQ46003731-E939FE74-F28A-4EA9-A85C-AC1BB811DD32
P2860
Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Translating research into evid ...... nity Clinical Oncology Program
@ast
Translating research into evid ...... nity Clinical Oncology Program
@en
Translating research into evid ...... nity Clinical Oncology Program
@nl
type
label
Translating research into evid ...... nity Clinical Oncology Program
@ast
Translating research into evid ...... nity Clinical Oncology Program
@en
Translating research into evid ...... nity Clinical Oncology Program
@nl
prefLabel
Translating research into evid ...... nity Clinical Oncology Program
@ast
Translating research into evid ...... nity Clinical Oncology Program
@en
Translating research into evid ...... nity Clinical Oncology Program
@nl
P2093
P2860
P356
P1433
P1476
Translating research into evid ...... nity Clinical Oncology Program
@en
P2093
Ann M O'Mara
Arnold D Kaluzny
Bryan J Weiner
Cynthia Whitman
Darrell E Anderson
Joseph Kelaghan
Lori M Minasian
Stefanie Nelson
William R Carpenter
Worta McCaskill-Stevens
P2860
P304
P356
10.1002/CNCR.25248
P407
P577
2010-10-01T00:00:00Z